Second-line oxaliplatin, folinic acid, and fluorouracil versus folinic acid and fluorouracil alone for gemcitabine-refractory pancreatic cancer: outcomes from the CONKO-003 trial - Oettle, H; Riess, H; Stieler, JM (J Clin Oncol, 2014)